Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public









Cancel


12>>>
28 Items
Title  Creator  Group name  Publishing year 
Stereotactic MR-Guided Radiotherapy for Liver Metastases: First Results of the Montpellier Prospective Registry Study Bordeau et al. EquipeJPP 2023-02-02
Robustness of Breast Margins with Volumetric Modulated Arc Therapy without a Six-Degrees-of-Freedom Couch: A Dosimetric Evaluation Prunaretty et al. EquipeJPP 2023-01-21
Implementation of the Calypso system: a commissioning experience Prunaretty et al. EquipeJPP 2023
A prospective registry study of stereotactic magnetic resonance guided radiotherapy (MRgRT) for primary liver tumors Bordeau et al. EquipeMY 2023-09-20
Stereotactic MR-Guided Radiotherapy for Pancreatic Tumors: Dosimetric Benefit of Adaptation and First Clinical Results in a Prospective Registry Study Michalet et al. EquipeMY 2022
Stereotactic MR-Guided Radiotherapy for Adrenal Gland Metastases: First Clinical Results Michalet et al. EquipeJPP 2022-12-30
Stereotactic MR-Guided Adaptive Radiotherapy for Pancreatic Tumors: Updated Results of the Montpellier Prospective Registry Study Bordeau et al. EquipeJPP 2022-12-20
Magnetic Resonance-Guided Reirradiation for Local Recurrence within the Prostate or in the Prostate Bed: One-Year Clinical Results of a Prospective Registry Study Michalet et al. EquipeJPP 2022-04-12
Efficacy, safety, and feasibility of volumetric modulated arc therapy for synchronous bilateral breast cancer management Quesada et al. EquipeJPP 2022
Different meaning of the mean heart dose between 3D-CRT and IMRT for breast cancer radiotherapy Prunaretty et al. EquipeJPP 2022
Quality assurance program and early toxicities in the phase III BONBIS randomized trial evaluating the role of a localized radiation boost in ductal carcinoma in situ Bourgier et al. EquipeJPP 2021-11
Prostate hypofractionated radiotherapy (62Gy at 3.1Gy per fraction) with injection of hyaluronic acid: final results of the RPAH1 study Chapet et al. EquipeJPP 2021-08-01
Image-Guided Liver Stereotactic Body Radiotherapy Using VMAT and Real-Time Adaptive Tumor Gating: Evaluation of the Efficacy and Toxicity for Hepatocellular Carcinoma Cantaloube et al. EquipeMY 2021-09-28
Long-term follow-up experience in anal canal cancer treated with Intensity-Modulated Radiation Therapy: Clinical outcomes, patterns of relapse and predictors of failure de Meric de Bellefon et al. EquipeJPP 2020-03
Intraoperative partial irradiation for highly selected patients with breast cancer: Results of the INTRAOBS prospective study Lemanski et al. EquipeCTCS 2020-04
Tracking, gating, free-breathing, which technique to use for lung stereotactic treatments? A dosimetric comparison Prunaretty et al. EquipeAP 2019 Jan-Feb
Management of the Axilla in the Era of Breast Cancer Heterogeneity de Meric de Bellefon et al. EquipeAP 2018
Independent component analysis for rectal bleeding prediction following prostate cancer radiotherapy Fargeas et al. EquipeAP 02 2018
Impact of adjuvant hormonotherapy on radiation-induced breast fibrosis according to the individual radiosensitivity: results of a multicenter prospective French trial Bourgier et al. EquipeNB Mar 20, 2018
SBRT planning for liver metastases: A focus on immobilization, motion management and planning imaging techniques Riou et al. EquipeMY 2017 Mar-Apr
Imaged-guided liver stereotactic body radiotherapy using VMAT and real-time adaptive tumor gating. Concerns about technique and preliminary clinical results Llacer-Moscardo et al. EquipeMY 2017 Mar-Apr
Evaluation of reproducibility of tumor repositioning during multiple breathing cycles for liver stereotactic body radiotherapy treatment Bedos et al. EquipeNB 2017 Mar-Apr
Helical tomotherapy and volumetric modulated arc therapy: New therapeutic arms in the breast cancer radiotherapy Lauche et al. EquipeNB Aug 28, 2016
Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial Azria et al. EquipeNB Dec 2015
Feasibility of accelerated partial breast irradiation with volumetric-modulated arc therapy in elderly and frail patients Riou et al. EquipeNB Oct 14, 2015
12>>>
28 Items


Who are we ?

Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).

U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)

More                                                                                                                 Join us

Contact us

Institut de Recherche en Cancérologie de
Montpellier (U1194) - Campus Val d'Aurelle

208 avenue des Apothicaires
34298 Montpellier cedex 5 FRANCE

 

insermUM1ICM

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés